MedTrace Logo

DNA Biomarkers in Samples From Patients With Osteosarcoma and Healthy Volunteers

NCT01139983 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2016-05-18

No results posted yet for this study

Summary

RATIONALE: Studying samples of blood and tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.

PURPOSE: This research study is studying DNA biomarkers in samples from patients with osteosarcoma and healthy volunteers.

Conditions

  • Sarcoma

Interventions

GENETIC

DNA analysis

GENETIC

RNA analysis

GENETIC

fluorescence in situ hybridization

GENETIC

microarray analysis

GENETIC

polymerase chain reaction

GENETIC

reverse transcriptase-polymerase chain reaction

OTHER

laboratory biomarker analysis

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Children's Oncology Group

    lead NETWORK

Principal Investigators

  • David Malkin, MD · The Hospital for Sick Children

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-04-30
Primary Completion
2016-05-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01139983 on ClinicalTrials.gov